trastuzumab deruxtecan-nxki
Enhertu Approved as HER2-Directed Therapy for Certain Lung Cancer Patients
The FDA granted a new indication for trastuzumab deruxtecan-nxki (Enhertu, AstraZeneca/Daiichi Sankyo) to treat ...
AUGUST 12, 2022
New Antibody Drug Conjugate May Become Metastatic Breast Cancer Standard
For second-line treatment of metastatic HER2-positive breast cancer, the new-generation antibody drug conjugate ...
DECEMBER 16, 2021
Load more